Cover Image

Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy

Abstract Background Duchenne muscular dystrophy (DMD) is a fatal disease for which no cure is available. Clinical trials have shown to be largely underpowered due to inter‐individual variability and noisy outcome measures. The availability of biomarkers able to anticipate clinical benefit is highly...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mirko Signorelli (Author), Burcu Ayoglu (Author), Camilla Johansson (Author), Hanns Lochmüller (Author), Volker Straub (Author), Francesco Muntoni (Author), Erik Niks (Author), Roula Tsonaka (Author), Anja Persson (Author), Annemieke Aartsma‐Rus (Author), Peter Nilsson (Author), Cristina Al‐Khalili Szigyarto (Author), Pietro Spitali (Author)
Format:	Book
Published:	Wiley, 2020-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
by: Pietro Spitali, et al.
Published: (2018)

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
by: van Ommen Gert-Jan B, et al.
Published: (2007)

Case Report: The Genetic Diagnosis of Duchenne Muscular Dystrophy in the Middle East
by: Fouad Alghamdi, et al.
Published: (2021)

Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress
by: Miranda D. Grounds, et al.
Published: (2020)

Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
by: Annemieke Aartsma-Rus
Published: (2022)

Assessment of the feasibility of exon 45-55 multiexon skipping for duchenne muscular dystrophy
by: van Ommen Gert-Jan B, et al.
Published: (2008)

Dictyostelium Differentiation-Inducing Factor-1 Binds to Mitochondrial Malate Dehydrogenase and Inhibits Its Activity
by: Tomoko Matsuda, et al.
Published: (2010)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
by: Daniele Capitanio, et al.
Published: (2020)

The use of genetically humanized animal models for personalized medicine approaches
by: Annemieke Aartsma-Rus, et al.
Published: (2020)

Salivary lactate dehydrogenase and salivary total protein as potential biomarkers for screening periodontal disease
by: Rasha Rawdhah, et al.
Published: (2023)

Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
by: van Ommen Gert Jan B, et al.
Published: (2011)

Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice
by: Flavien Bizot, et al.
Published: (2022)

Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials
by: Sarah Kim, et al.
Published: (2023)

Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
by: Dominique O. Riddell, et al.
Published: (2022)

Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
by: Silvana M G Jirka, et al.
Published: (2015)

Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients
by: Jessy Etienne, et al.
Published: (2020)

Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children
by: Ta-Yu Liu, et al.
Published: (2018)

Preclinical Studies on Intestinal Administration of Antisense Oligonucleotides as a Model for Oral Delivery for Treatment of Duchenne Muscular Dystrophy
by: Maaike van Putten, et al.
Published: (2014)

Acute Lung Injury Biomarkers in the Prediction of COVID-19 Severity: Total Thiol, Ferritin and Lactate Dehydrogenase
by: Alvaro Martinez Mesa, et al.
Published: (2021)

LW1497, an Inhibitor of Malate Dehydrogenase, Suppresses TGF-β1-Induced Epithelial-Mesenchymal Transition in Lung Cancer Cells by Downregulating Slug
by: Hyun Ji Kim, et al.
Published: (2021)

Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis
by: Yan Xia, et al.
Published: (2018)

Orphan Medicine Incentives: How to Address the Unmet Needs of Rare Disease Patients by Optimizing the European Orphan Medicinal Product Landscape Guiding Principles and Policy Proposals by the European Expert Group for Orphan Drug Incentives (OD Expert Group)
by: Annemieke Aartsma-Rus, et al.
Published: (2021)

Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19
by: Soojin Shim, et al.
Published: (2020)

A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
by: Basma A. Al-Mshhdani, et al.
Published: (2021)

Imaging Biomarkers or Biomarker Imaging?
by: Markus Mitterhauser, et al.
Published: (2014)

Oxidative Stress in Peripheral Arterial Disease (PAD) Mechanism and Biomarkers
by: Salvatore Santo Signorelli, et al.
Published: (2019)

The Impacts of Graded Doses of Pyridoxine on the Biomarkers, Aspartate Aminotransferase, lactate Dehydrogenase and Total Antioxidant Capacity in Doxorubicin-Induced Cardiotoxicity in Female Rats
by: Doaa Kadhim Abdul Ridha, et al.
Published: (2017)

The Impacts of Graded Doses of Pyridoxine on the Biomarkers, Aspartate Aminotransferase, lactate Dehydrogenase and Total Antioxidant Capacity in Doxorubicin-Induced Cardiotoxicity in Female Rats
by: Doaa Kadhim Abdul Ridha, et al.
Published: (2017)

Biomarker
Published: (2012)

HMGB1 Is a Potential Biomarker for Severe Viral Hemorrhagic Fevers.
by: Katarina Resman Rus, et al.
Published: (2016)

A study on biomarker, serum lactate dehydrogenase, as an early predictor of complications and disease severity in sickle cell disease patients in tertiary care hospital
by: Jolly Rabha
Published: (2024)

Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)
by: Raffaella Willmann, et al.
Published: (2020)

To dystrophin and beyond: an interview with Louis Kunkel
by: Louis M. Kunkel, et al.
Published: (2020)

At the heart of genetic disease: an interview with Elizabeth McNally
by: Elizabeth McNally, et al.
Published: (2020)

Moving neuromuscular disorders research forward: from novel models to clinical studies
by: Maaike van Putten, et al.
Published: (2020)

Comprehensive RNA-Sequencing Analysis in Serum and Muscle Reveals Novel Small RNA Signatures with Biomarker Potential for DMD
by: Anna M.L. Coenen-Stass, et al.
Published: (2018)

Sudden cardiac death of Duchenne muscular dystrophy with NT-proBNP in pericardial fluid as a useful biomarker for diagnosis of the cause of death: a case report
by: Mengzhou Zhang, et al.
Published: (2020)

Identification of new biomarkers for sarcopenia and characterization of cathepsin D biomarker
by: Corine L'hôte, et al.
Published: (2021)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
by: Gilles Duvoisin, et al.
Published: (2017)

Biomarkers in Neurology
Published: (2020)